Clinical Trials Browser

INDUSTRY × brigatinib × 1 year × Clear all

NCT05721950 2026-02-18

Brilliant

Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT03596866 2025-09-12

ALTA-3

Phase 3 Completed

248 enrolled 20 charts

ALK+ Advanced NSCLC

NCT03535740 2025-07-31

ALTA-2

Phase 2 Completed

103 enrolled 23 charts

ALK-positive Advanced NSCLC

NCT05834348 2025-03-30

DELINOR

5,279 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung